Endoscopic Submucosal Dissection Market Size, Share & Trends Analysis Report By Product (Gastroscopes & Colonoscopes, Knives), By Indication (Stomach Cancer, Colon Cancer, Esophageal Cancer), By End Use, By Region, And Segment Forecasts, 2025 - 2030

Market Size & Trends

The global endoscopic submucosal dissection market was valued at USD 370.4 million in 2024 and is projected to grow at a CAGR of 5.5% from 2025 to 2030. The increasing prevalence of gastrointestinal cancers and other related disorders and advancements in endoscopic technology & instrumentation drive the demand for diagnostic and therapeutic procedures such as ESD. For instance, the American Cancer Society estimates that in 2024, there will be 26,890 new cases of stomach cancer, with 10,730 cases in women and 16,160 cases in men. As esophageal, gastric, and colorectal cancer rates continue to rise globally, the need for advanced procedures, such as ESD, is increasing.

Furthermore, the aging population worldwide is boosting the demand for ESD. As the global population ages, age-related gastrointestinal conditions, including cancers, are expected to rise. According to the American Cancer Society, gastric cancer predominantly affects older individuals, with an average age of 68 when diagnosed, and 6 out of 10 diagnosed annually are 65 or older. Many older patients also have other health conditions, which make traditional surgery riskier, further contributing to the rising demand for ESD procedures.

The development of high-definition endoscopes, improved electrosurgical knives, and enhanced imaging techniques have significantly increased the precision and safety of ESD procedures. These technological innovations have improved the efficacy of the treatment and expanded the indications for ESD, allowing it to be used for a broader range of lesions. Moreover, integrating artificial intelligence and machine learning in endoscopic procedures enhances diagnostic accuracy and procedural outcomes, further propelling market growth. For instance, in September 2024, Odin Medical Ltd. (Olympus Corporation company) obtained U.S. FDA 510(k) clearance for its CADDIE computer-aided detection (CADe). It is a cloud-based AI technology developed to help gastroenterologists to detect colorectal polyps during colonoscopy procedures.

The growing awareness and training programs for healthcare professionals in ESD techniques contribute to market growth. The proficiency of gastroenterologists and surgeons in ESD has been increasing, enhancing both the reach and feasibility of this advanced procedure, particularly in areas that previously had limited access to such treatments. Various medical organizations offer specialized training and certification programs, which are important in gaining knowledge and expertise in ESD. For instance, in April 2024, FUJIFILM Healthcare Europe GmbH introduced EndoGel, an innovative training model designed for performing Peroral Endoscopic Myotomy (POEM) and Endoscopic Submucosal Dissection (ESD) procedures. This simulator is available in two versions such as EndoGel for ESD/POEM and EndoGel for ESD. It is designed to be cost-effective for endoscopy professionals and healthcare institutions, aiming to enhance proficiency and patient outcomes through realistic simulation training.

Global Endoscopic Submucosal Dissection Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global endoscopic submucosal dissection market report on the basis of product, indication, end use, and regions.

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Gastroscopes and Colonoscopes
• Knives
• Injection Agents
• Tissue Retractors
• Graspers/ Clips
• Other Products
• Indication Outlook (Revenue, USD Million, 2018 - 2030)
• Stomach Cancer
• Colon Cancer
• Esophageal Cancer
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals {Including inpatient departments and hospital outpatient departments (HOPDs)}
• Outpatient Facilities {Including ambulatory surgical centers (ASCs), clinics, and other outpatient care settings}
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

• Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

• Latin America

Brazil

Argentina

• Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait